These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 22521002

  • 1. Refractory relapsing polychondritis in a child treated with antiCD20 monoclonal antibody (rituximab): first case report.
    Abdwani R, Kolethekkat AA, Al Abri R.
    Int J Pediatr Otorhinolaryngol; 2012 Jul; 76(7):1061-4. PubMed ID: 22521002
    [Abstract] [Full Text] [Related]

  • 2. Childhood pemphigus vulgaris successfully treated with rituximab.
    Kanwar AJ, Sawatkar GU, Vinay K, Hashimoto T.
    Indian J Dermatol Venereol Leprol; 2012 Jul; 78(5):632-4. PubMed ID: 22960821
    [Abstract] [Full Text] [Related]

  • 3. Infliximab in relapsing polychondritis.
    de Barros AP, Nakamura NA, Santana Tde F, Motta JQ, Bianchi WA.
    Rev Bras Reumatol; 2010 Jul; 50(2):211-6. PubMed ID: 21125156
    [Abstract] [Full Text] [Related]

  • 4. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
    Kisner T, Burst V, Teschner S, Benzing T, Kurschat CE.
    Nephron Clin Pract; 2012 Jul; 120(2):c79-85. PubMed ID: 22286071
    [Abstract] [Full Text] [Related]

  • 5. Sustained response to etanercept after failing infliximab, in a patient with relapsing polychondritis with tracheomalacia.
    Subrahmanyam P, Balakrishnan C, Dasgupta B.
    Scand J Rheumatol; 2008 Jul; 37(3):239-40. PubMed ID: 18465465
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of relapsing polychondritis with rituximab: a retrospective study of nine patients.
    Leroux G, Costedoat-Chalumeau N, Brihaye B, Cohen-Bittan J, Amoura Z, Haroche J, Limal N, Bletry O, Piette JC.
    Arthritis Rheum; 2009 May 15; 61(5):577-82. PubMed ID: 19405005
    [Abstract] [Full Text] [Related]

  • 7. [Sustained response with tocilizumab in a case of refractory relapsing polychondritis].
    Weber E, Gaultier JB, Paul S, Guichard I, Monard E, Cathébras P.
    Rev Med Interne; 2014 Mar 15; 35(3):196-8. PubMed ID: 24074969
    [Abstract] [Full Text] [Related]

  • 8. Long-term response to rituximab in patients with relapsing thrombotic thrombocytopenic purpura.
    Stein GY, Blickstein D, Orlin J, Sarig G, Inbal A.
    Isr Med Assoc J; 2011 Jul 15; 13(7):398-401. PubMed ID: 21838180
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab.
    Geissal ED, Wernick R.
    J Clin Rheumatol; 2010 Jun 15; 16(4):185-7. PubMed ID: 20414125
    [Abstract] [Full Text] [Related]

  • 11. Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy.
    D'Amico A, Catteruccia M, De Benedetti F, Vivarelli M, Colucci M, Cascioli S, Bertini E.
    Eur J Paediatr Neurol; 2012 May 15; 16(3):301-3. PubMed ID: 21903431
    [Abstract] [Full Text] [Related]

  • 12. Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis.
    Brown JW, Martin PJ, Thorpe JW, Michell AW, Coles AJ, Cox AL, Vincent A, Zandi MS.
    J Neuroimmunol; 2014 Jun 15; 271(1-2):66-8. PubMed ID: 24703099
    [Abstract] [Full Text] [Related]

  • 13. Sustained response to infliximab in 2 patients with refractory relapsing polychondritis.
    Saadoun D, Deslandre CJ, Allanore Y, Pham XV, Kahan A.
    J Rheumatol; 2003 Jun 15; 30(6):1394-5. PubMed ID: 12784426
    [No Abstract] [Full Text] [Related]

  • 14. Relapsing polychondritis, an underestimated dermatological urgency: case report and literature review.
    Cuestas D, Peñaranda E, Mora S, Cortes C, Galvis I, Patiño M, Velasquez O.
    Int J Dermatol; 2017 Dec 15; 56(12):1379-1386. PubMed ID: 28994110
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of relapsing polychondritis with infliximab.
    Richez C, Dumoulin C, Coutouly X, Schaeverbeke T.
    Clin Exp Rheumatol; 2004 Dec 15; 22(5):629-31. PubMed ID: 15485019
    [Abstract] [Full Text] [Related]

  • 16. [Relapsing polychondritis with mental disorders: a case report].
    Watanabe T, Yasuda Y, Tanaka H, Akiguchi I.
    Rinsho Shinkeigaku; 1997 Mar 15; 37(3):243-8. PubMed ID: 9217425
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
    Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P, French Thrombotic Microangiopathies Reference Center.
    Crit Care Med; 2012 Jan 15; 40(1):104-11. PubMed ID: 21926591
    [Abstract] [Full Text] [Related]

  • 18. Infliximab in a patient with refractory necrotizing scleritis associated with relapsing polychondritis.
    Jabbarvand M, Fard MA.
    Ocul Immunol Inflamm; 2010 Jun 15; 18(3):216-7. PubMed ID: 20482401
    [Abstract] [Full Text] [Related]

  • 19. Hypopyon uveitis and relapsing polychondritis: a report of 2 patients and review of autoimmune hypopyon uveitis.
    Anderson NG, Garcia-Valenzuela E, Martin DF.
    Ophthalmology; 2004 Jun 15; 111(6):1251-4. PubMed ID: 15177981
    [Abstract] [Full Text] [Related]

  • 20. Relapsing polychondritis: a rare disease of multisystem involvement.
    Paudyal BP, Karki A, Zimmerman M.
    JNMA J Nepal Med Assoc; 2007 Jun 15; 46(166):81-3. PubMed ID: 18094743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.